FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Morey Blinder

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Procedures

Cloning, Molecular

Co-author Network

Publications

TOP 3
Morey A Blinder; Carole Paley; Medha Sasane; Alex Trahey; Francis Vekeman; Mei Sheng Duh
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
Jessica E Knight-Perry; Alan D Waggoner; Raymond G Hoffmann; Morey A Blinder; Victor G Dávila-Román; Lisa de las Fuentes; Joshua J Field
Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension.
Robyn T Cohen; Michael R DeBaun; Anusha Madadi; Robert C Strunk; Morey A Blinder; Joshua J Field
Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Morey Blinder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Morey A Blinder; Carole Paley; Medha Sasane; Alex Trahey; Francis Vekeman; Mei Sheng Duh
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
Pediatric blood & cancer 2013;60(5):828-35.
2011: Jessica E Knight-Perry; Alan D Waggoner; Raymond G Hoffmann; Morey A Blinder; Victor G Dávila-Román; Lisa de las Fuentes; Joshua J Field
Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2011;24(11):1285-90.
2011: Robyn T Cohen; Michael R DeBaun; Anusha Madadi; Robert C Strunk; Morey A Blinder; Joshua J Field
Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.
American journal of hematology 2011;86(9):756-61.
2010: Robyn T Cohen; Michael R DeBaun; Morey A Blinder; Robert C Strunk; Joshua J Field
Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease.
Blood 2010;115(18):3852-4.
2010: Morey A Blinder
Commentary.
Clinical chemistry 2010;56(1):19-20.
2009: Huichung T Ling; Joshua J Field; Morey A Blinder
Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
American journal of hematology 2009;84(7):418-21.
2009: Joshua J Field; Robert C Strunk; Jessica E Knight-Perry; Morey A Blinder; R Reid Townsend; Michael R DeBaun
Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
American journal of hematology 2009;84(4):231-3.
2009: Joshua J Field; James Krings; Nicole L White; Yan Yan; Morey A Blinder; Robert C Strunk; Michael R DeBaun
Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease.
American journal of hematology 2009;84(3):158-60.
2008: Alan E Mast; Morey A Blinder; Dennis J Dietzen
Reticulocyte hemoglobin content.
American journal of hematology 2008;83(4):307-10.
2008: Trudie Goers; Julie Panepinto; Michael R DeBaun; Morey A Blinder; Robert Foglia; Keith T Oldham; Joshua J Field
Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay.
Pediatric blood & cancer 2008;50(3):603-6.
2007: Maxwell M Krem; Lihua Pan; Morey A Blinder
(18)F-FDG-PET-facilitated diagnosis of lymphoma presenting with fever of unknown origin and cold agglutination.
Leukemia & lymphoma 2007;48(3):619-22.
2007: Michelle W Lau; Morey A Blinder; Kimberly Williams; Leesa M Galatz
Shoulder arthroplasty in sickle cell patients with humeral head avascular necrosis.
Journal of shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.] 2007;16(2):129-34.
2007: Joshua J Field; T S Fenske; Morey A Blinder
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(1):46-50.
2006: Joshua J Field; Leonard Giannone; Monica Bessler; Morey A Blinder
Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failure.
Pharmacotherapy 2006;26(11):1662-6.
2004: Dmitri V Kravtsov; Wenman Wu; Joost C M Meijers; Mao-Fu Sun; Morey A Blinder; Thao P Dang; Hongli Wang; David Gailani
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.
Blood 2004;104(1):128-34.
2003: Xinglong Zheng; Arnel M Pallera; Lawrence T Goodnough; J Evan Sadler; Morey A Blinder
Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
Annals of internal medicine 2003;138(2):105-8.
2002: Alan E Mast; Morey A Blinder; Qing Lu; Sherri Flax; Dennis J Dietzen
Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency.
Blood 2002;99(4):1489-91.
1998: D Chen; Timothy R Wilhite; Carl H Smith; Morey A Blinder; Michael Landt
HPLC detection of fetal blood in meconium: improved sensitivity compared with qualitative methods.
Clinical chemistry 1998;44(11):2277-80.
1998: Niall Colwell; Morey A Blinder; Manuel Tsiang; Craig S Gibbs; Paul E Bock; Douglas M Tollefsen
Allosteric effects of a monoclonal antibody against thrombin exosite II.
Biochemistry 1998;37(43):15057-65.
1998: Alan E Mast; Morey A Blinder; Ann M Gronowski; C Chumley; Mitchell G Scott
Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations.
Clinical chemistry 1998;44(1):45-51.
1997: Niall Colwell; Douglas M Tollefsen; Morey A Blinder
Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.
British journal of haematology 1997;97(1):219-26.
1991: Herbert C Whinna; Morey A Blinder; M Szewczyk; Douglas M Tollefsen; Frank Church
Role of lysine 173 in heparin binding to heparin cofactor II.
The Journal of biological chemistry 1991;266(13):8129-35.
1991: R Herzog; S Lutz; nikolaus blin; J C Marasa; Morey A Blinder; Douglas M Tollefsen
Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11.
Biochemistry 1991;30(5):1350-7.
1990: V M Derechin; Morey A Blinder; Douglas M Tollefsen
Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
The Journal of biological chemistry 1990;265(10):5623-8.
1990: Morey A Blinder; Douglas M Tollefsen
Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
The Journal of biological chemistry 1990;265(1):286-91.
1989: Morey A Blinder; T R Andersson; U Abildgaard; Douglas M Tollefsen
Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
The Journal of biological chemistry 1989;264(9):5128-33.
1988: Morey A Blinder; J C Marasa; C H Reynolds; L L Deaven; Douglas M Tollefsen
Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli.
Biochemistry 1988;27(2):752-9.